Suh, W Warren <br/><br/>
A phase I dose escalation trial of gemcitabine with radiotherapy for breast cancer in the treatment of unresectable chest wall recurrences.  [electronic resource] 

 -  The breast journal   
 - 204-10 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1075-122X 
<br/><br/><label>Standard No.: </label>10.1111/j.1075-122X.2004.21305.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Radiation-Sensitizing Agents--administration & dosage<br/>Radiotherapy, Adjuvant<br/>Survival Analysis<br/>Thoracic Wall--pathology<br/>Time Factors<br/>Treatment Outcome<br/>Gemcitabine